Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lisofer
- Development stage
- Preclinical
- Lead developer
- Canadex Laboratories
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Oral
01
Overview
**Lisofer** is an oral liposomal iron nutritional product used for iron replacement. In the non-dialysis chronic kidney disease anemia study conducted at Hassan II University Hospital in Fès, the evaluated Lisofer 30 formulation provided 30 mg liposomal ferric pyrophosphate plus 70 mg ascorbic acid daily. Ferric pyrophosphate is microencapsulated in a lipid-based delivery system intended to improve gastrointestinal tolerability and intestinal iron delivery; absorbed iron supports hemoglobin production and erythropoiesis. A randomized Phase 4 non-inferiority study compared this oral formulation with intravenous iron sucrose in patients with iron-deficiency anemia and non-dialysis chronic kidney disease. ([pdfs.semanticscholar.org](https://pdfs.semanticscholar.org/5244/0551a0039a98ebe2ad1758ee32f3855ad6bb.pdf))
- Brand names
- LisoferLisofer 30Lisofer30Lisofer-30
Beyond the preview
Go deeper on Lisofer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lisofer.